These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384 [TBL] [Abstract][Full Text] [Related]
45. [Identify nature N-acylethanolamide-hydrolyzing acid amide (NAAA) inhibitor: effect of angelicae pubescentis radix on anti-inflammation]. Sun W; Yang L; Qiu Y; Ren J; Huang R; Fu J Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(22):3161-6. PubMed ID: 22375399 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of triple negative breast cancer-associated inflammation and progression by N- acylethanolamine acid amide hydrolase (NAAA). Benchama O; Malamas MS; Praveen K; Ethier EC; Williams MK; Makriyannis A; Avraham HK Sci Rep; 2022 Dec; 12(1):22255. PubMed ID: 36564457 [TBL] [Abstract][Full Text] [Related]
49. Lysosome targeting fluorescent probe for NAAA imaging and its applications in the drug development for anti-inflammatory. Zhou L; Tian M; Zhang B; Cao X; Huo X; Yang F; Cao P; Feng L; Ma X; Tian X Int J Biol Macromol; 2024 Apr; 263(Pt 2):130307. PubMed ID: 38382784 [TBL] [Abstract][Full Text] [Related]
50. N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis. Pontis S; Palese F; Summa M; Realini N; Lanfranco M; De Mei C; Piomelli D Pharmacol Res; 2020 Oct; 160():105064. PubMed ID: 32634582 [TBL] [Abstract][Full Text] [Related]
52. N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships. Duranti A; Tontini A; Antonietti F; Vacondio F; Fioni A; Silva C; Lodola A; Rivara S; Solorzano C; Piomelli D; Tarzia G; Mor M J Med Chem; 2012 May; 55(10):4824-36. PubMed ID: 22515328 [TBL] [Abstract][Full Text] [Related]
53. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies. Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942 [TBL] [Abstract][Full Text] [Related]
54. Discovery of Uracil Derivatives as Potent Inhibitors of Fatty Acid Amide Hydrolase. Qiu Y; Zhang Y; Li Y; Ren J Molecules; 2016 Feb; 21(2):. PubMed ID: 26901181 [TBL] [Abstract][Full Text] [Related]
55. Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer. Vago R; Bettiga A; Salonia A; Ciuffreda P; Ottria R Bioorg Med Chem; 2017 Feb; 25(3):1242-1249. PubMed ID: 28062195 [TBL] [Abstract][Full Text] [Related]
57. Genetic Blockade of NAAA Cell-specifically Regulates Fatty Acid Ethanolamides (FAEs) Metabolism and Inflammatory Responses. Xie X; Li Y; Xu S; Zhou P; Yang L; Xu Y; Qiu Y; Yang Y; Li Y Front Pharmacol; 2021; 12():817603. PubMed ID: 35069223 [TBL] [Abstract][Full Text] [Related]
58. Natural Potent NAAA Inhibitor Atractylodin Counteracts LPS-Induced Microglial Activation. Yang L; Ji C; Li Y; Hu F; Zhang F; Zhang H; Li L; Ren J; Wang Z; Qiu Y Front Pharmacol; 2020; 11():577319. PubMed ID: 33117168 [No Abstract] [Full Text] [Related]
59. Harnessing the anti-inflammatory potential of palmitoylethanolamide. Alhouayek M; Muccioli GG Drug Discov Today; 2014 Oct; 19(10):1632-9. PubMed ID: 24952959 [TBL] [Abstract][Full Text] [Related]
60. Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain. Petrosino S; Ahmad A; Marcolongo G; Esposito E; AllarĂ M; Verde R; Cuzzocrea S; Di Marzo V Pharmacol Res; 2015 Jan; 91():9-14. PubMed ID: 25447594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]